Skip to content
Category

Immunology

page 2
breakthrough infection
infection following vaccine administration
natural killer T cell
group of T cells that share properties of both T cells and natural killer (NK) cells
damage-associated molecular pattern
concentration of molecules within cells from the innate immune response released by damaged or dying cells, after trauma or an infection
immunostimulant
Immunostimulants, also known as immunostimulators, are substances (drugs and nutrients) that stimulate the immune system usually in a non-specific manner by inducing activation or increasing activity of any of its components. One notable example is the granulocyte macrophage colony-stimulating factor. The goal of this stimulated immune response is usually to help the body have a stronger immune system response in order to improve outcomes in the case of an infection or cancer malignancy. There is also some evidence that immunostimulants may be useful to help decrease severe acute illness relat
isotype
any of the related proteins/genes from a particular gene family
peripheral tolerance
term
clonal anergy
functional inactivation of T- or B-lymphocytes
antibody-drug conjugate
class of biopharmaceutical drug
immunologic adjuvant
substances that augment, stimulate, activate, potentiate or modulate the immune response
immunogen
An immunogen is any substance that generates B-cell (humoral/antibody) and/or T-cell (cellular) adaptive immune responses upon exposure to a host organism. Immunogens that generate antibodies are called antigens ("antibody-generating"). Immunogens that generate antibodies are directly bound by host antibodies and lead to the selective expansion of antigen-specific B-cells. Immunogens that generate T-cells are indirectly bound by host T-cells after processing and presentation by host antigen-presenting cells.
fragment crystallizable region
tail region of an antibody
muromonab
Muromonab-CD3 (brand name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant medication given to reduce acute rejection in people with organ transplants. It is a monoclonal antibody targeted at the CD3 receptor, a membrane protein on the surface of T cells. It is the first monoclonal antibody to be approved for clinical use in humans.
CD3 complex
protein complex and T cell co-receptor
central tolerance
mechanism by which newly developing T cells and B cells are rendered non-reactive to self
Original antigenic sin
immune phenomenon
blinatumomab
Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used for the treatment of Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. It belongs to a class of constructed monoclonal antibodies, bi-specific T-cell engagers (BiTEs), that exert action selectively and direct the human immune system to act against tumor cells. Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that specifically targets the CD19 antigen present on B cells. Blinatumomab is given via intravenous infusion.
buffy coat
component of blood
Autoimmune regulator
mammalian protein found in Homo sapiens
tetraspanin
thumb|Hypothetical model of the tetraspanin function
Titer
Titer (American English) or titre (British English) is a way of expressing concentration. Titer testing employs serial dilution to obtain approximate quantitative information from an analytical procedure that inherently only evaluates as positive or negative. The titer corresponds to the highest dilution factor that still yields a positive reading. For example, positive readings in the first 8 serial, twofold dilutions translate into a titer of 1:256 (i.e., 2−8). Titres are sometimes expressed by the denominator only, for example 1:256 is written 256.
TNF inhibitor
pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF)
Rho(D) immune globulin
medication used to prevent RhD isoimmunization
immunosenescence
thumb|alt=Immunosenescence|Immunosenescence Immunosenescence is the gradual deterioration of the immune system, brought on by natural age advancement. It affects both innate and adaptive immunity, including changes in lymphocyte production, immune cell function, and inflammatory regulation. Immunosenescence involves both the host's capacity to respond to infections and the development of long-term immune memory. Age-associated immune deficiency is found in both long- and short-lived species as a function of their age relative to life expectancy rather than elapsed time.
Immunoglobulin-like domain superfamily
large protein superfamily of cell surface and soluble proteins
pluripotency
ability of certain substances to produce several distinct biological responses
parabiosis
Parabiosis is a laboratory technique used in physiological research, derived from the Greek word meaning "living beside." The technique involves the surgical joining of two living organisms in such a way that they develop a single, shared physiological system. Through this approach, researchers can study the exchange of blood, hormones, and other substances between the two organisms, allowing for the examination of a wide range of physiological phenomena and interactions. Parabiosis has been employed in various fields of study, including stem cell research, endocrinology, aging research, and i
B cell affinity maturation
cellular process in B cells
pleocytosis
In medicine, pleocytosis (or pleiocytosis) is an increased cell count (from Greek pleion, "more"), particularly an increase in white blood cell count, in a bodily fluid, such as cerebrospinal fluid. It is often defined specifically as an increased white blood cell count in cerebrospinal fluid.
evasion of host immune response
Any mechanism of immune avoidance that directly affects the host immune system, e.g. blocking any stage in host MHC class I and II presentation. The host is defined as the larger of the organisms involved in a symbiotic interaction.
immune privilege
localised phenomenon where the presence of antigens does not trigger an immune response
Immune tolerance in pregnancy
Tolerance of a fetus during pregnancy
complementarity determining region
part of the variable chains in immunoglobulins (antibodies) and T cell receptors, generated by B-cells and T-cells respectively
Alloimmunity
Alloimmunity (sometimes called isoimmunity) is an immune response to nonself antigens from members of the same species, which are called alloantigens or isoantigens. Two major types of alloantigens are blood group antigens and histocompatibility antigens. In alloimmunity, the body creates antibodies (called alloantibodies) against the alloantigens, attacking transfused blood, allotransplanted tissue, and even the fetus in some cases. Alloimmune (isoimmune) response results in graft rejection, which is manifested as deterioration or complete loss of graft function. In contrast, autoimmunity is
IFNL1
protein-coding gene in the species Homo sapiens
D-(+)-neopterin
Neopterin is an organic compound belonging to the pteridine class of heterocyclic compounds.
immunohaematology
Immunohematology is a branch of hematology and transfusion medicine which studies antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. A person employed in this field is referred to as an immunohematologist or colloquially as a blood banker. Their day-to-day duties include blood typing, cross-matching and antibody identification. alt=Red White Blood cells.jpg|thumb| Immunohematology and Transfusion Medicine is a medical post graduate specialty in many countries. The specialist Immunohematology and Transfusion Phys
naive B cell
cell type
cross-presentation
Cross-presentation is the ability of certain professional antigen-presenting cells (mostly dendritic cells) to take up, process and present extracellular antigens with MHC class I molecules to CD8 T cells (cytotoxic T cells). Cross-priming, the result of this process, describes the stimulation of naive cytotoxic CD8+ T cells into activated cytotoxic CD8+ T cells. This process is necessary for immunity against most tumors and against viruses that infect dendritic cells and sabotage their presentation of virus antigens. Cross presentation is also required for the induction of cytotoxic immunity
CRTC1
CREB-regulated transcription coactivator 1 (CRTC1), previously referred to as TORC1 (), is a protein that in humans is encoded by the CRTC1 gene. It is expressed in a limited number of tissues that include fetal brain and liver and adult heart, skeletal muscles, liver and salivary glands and various regions of the adult central nervous system.
degranulation
thumb|300px|right|The degranulation process in a Mast cell. 1 = antigen; 2 = [[IgE; 3 = FcεR1; 4 = preformed mediators (histamine, proteases, chemokines, heparin); 5 = granules; 6 - Mast cell; 7 - newly formed mediators (prostaglandins, leukotrienes, thromboxanes, platelet-activating factor)]] Degranulation is a cellular process that releases antimicrobial, cytotoxic, or other molecules from secretory vesicles called granules found inside some cells. It is used by several different cells involved in the immune system, including granulocytes (neutrophils, basophils, eosinophils, and mast cells)
lymphocyte function-associated antigen 1
Lfa-1
Antigen-antibody interaction
immune response chemical interaction
monoclonal antibody therapy
form of immunotherapy
Co-stimulation
Co-stimulation is a secondary signal which immune cells rely on to activate an immune response in the presence of an antigen-presenting cell. In the case of T cells, two stimuli are required to fully activate their immune response. During the activation of lymphocytes, co-stimulation is often crucial to the development of an effective immune response. Co-stimulation is required in addition to the antigen-specific signal from their antigen receptors.
5S-HETE
chemical compound. this family of metabolites serve as hormone-like autocrine and paracrine signalling agents that contribute to the up-regulation of acute inflammatory and allergic responses.
clonal deletion
process by which B cells and T cells are deactivated before act significantly upon specific antigens
Polyclonal B cell response
immune response exhibited by the adaptive immune system
William B. Coley Award
American award for cancer immunology research
sensitization
induction of an adaptive response in the immune system, either for immunization to disease or as allergy
vaccine passport during the COVID-19 pandemic
immunity passport used to prove that one has received a COVID-19 vaccination
Antigenicity
REDIRECT Immunogenicity
B-1 cell
B cell lymphocytes
TNFRSF9
CD137, a member of the tumor necrosis factor (TNF) receptor family, is a type 1 transmembrane protein, expressed on surfaces of leukocytes and non-immune cells. Its alternative names are tumor necrosis factor receptor superfamily member 9 (TNFRSF9), 4-1BB, and induced by lymphocyte activation (ILA). It is of interest to immunologists as a co-stimulatory immune checkpoint molecule, and as a potential target in cancer immunotherapy.
12S-HETE
chemical compound
complement-dependent cytotoxicity
Lysis of a cell resulting from triggering of the complement cascade. An example can be seen with complement activation and subsequent lysis of a bacterial cell as a result of the binding of IgM to the cell surface followed by the binding of complemen
immunoediting
Immunoediting is a dynamic process that consists of immunosurveillance and tumor progression. It describes the relation between the tumor cells and the immune system. It is made up of three phases: elimination, equilibrium, and escape.
immunocompetence
In immunology, immunocompetence is the ability of the body to produce a normal immune response following exposure to an antigen. Immunocompetence is the opposite of immunodeficiency (also known as immuno-incompetence or being immuno-compromised).
serodiscordance
A serodiscordant relationship, also known as mixed-status, is one where one partner is infected by HIV and the other is not. This contrasts with seroconcordant relationships, in which both partners are of the same HIV status. Without effective prevention measures, serodiscordant relationships can significantly contribute to the spread of HIV/AIDS, with the risk varying based on the type and frequency of sexual activity and the viral load of the HIV-positive partner.
tilomisole
Tilomisole (WY-18,251) is an experimental drug which acts as an immunomodulator and has been studied for the treatment of some forms of cancer.
hepoxilin
Hepoxilins (Hx) are a set of epoxyalcohol metabolites of polyunsaturated fatty acids (PUFA), i.e. they possess both an epoxide and an alcohol (i.e. hydroxyl) residue. HxA3, HxB3, and their non-enzymatically formed isomers are nonclassic eicosanoid derived from acid the (PUFA), arachidonic acid. A second group of less well studied hepoxilins, HxA4, HxB4, and their non-enzymatically formed isomers are nonclassical eicosanoids derived from the PUFA, eicosapentaenoic acid. Recently, 14,15-HxA3 and 14,15-HxB3 have been defined as arachidonic acid derivatives that are produced by a different metabol